FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention

JACC Heart Fail. 2017 Feb;5(2):152-153. doi: 10.1016/j.jchf.2016.11.010.

Authors

Mona Fiuzat¹, Tamar S Nordenberg², Mitchell Zeller², Matthew G Hillebrenner², Norman Stockbridge², Bram Zuckerman², Robert M Califf²

Affiliations

¹ U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: [email protected].
² U.S. Food and Drug Administration, Silver Spring, Maryland.

PMID: 28153199
DOI: 10.1016/j.jchf.2016.11.010

No abstract available

Keywords: FDA; drug evaluation; stroke.

Publication types

Editorial

MeSH terms

Health Policy / legislation & jurisprudence*
Heart Failure / prevention & control*
Humans
Nicotiana
Smoking Prevention / legislation & jurisprudence*
United States
United States Food and Drug Administration*